{"entity":{"type":"insider","cik":"0001442372","url":"/insider/0001442372","json_url":"/insider/0001442372.json","name":"Sabba Stephen L","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":13,"first":"2011-11-14","last":"2026-06-18","span_basis":"filed_date"},"name_variants":[{"name":"Sabba Stephen L","source":"filing","n_filings":13,"first_seen":"2011-11-14","last_seen":"2026-06-18"}],"transactions":[{"id":6034846,"accession":"0001104659-26-075456","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-26-075456","line_url":"/filing/0001104659-26-075456#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001442372","owner_name":"Sabba Stephen L","owner_display_name":"Sabba Stephen L","owner_url":"/insider/0001442372","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2145.0,"shares_display":"2,145","price_per_share":254.0,"price_display":"254.00","price_state":"stated","total_value":544830.0,"total_display":"544,830.00","total_whole":"544,830","shares_owned_after":33629.0,"shares_owned_after_display":"33,629","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-16","filed_date":"2026-06-18","scope":"insider"},{"id":5999439,"accession":"0001104659-26-034308","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-034308","line_url":"/filing/0001104659-26-034308#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001442372","owner_name":"Sabba Stephen L","owner_display_name":"Sabba Stephen L","owner_url":"/insider/0001442372","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":207.8727,"price_display":"207.87","price_state":"stated","total_value":207872.7,"total_display":"207,872.70","total_whole":"207,873","shares_owned_after":32793.0,"shares_owned_after_display":"32,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-23","filed_date":"2026-03-25","scope":"insider"},{"id":6168762,"accession":"0001104659-26-023943","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-26-023943","line_url":"/filing/0001104659-26-023943#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001442372","owner_name":"Sabba Stephen L","owner_display_name":"Sabba Stephen L","owner_url":"/insider/0001442372","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2034.0,"shares_display":"2,034","price_per_share":201.5,"price_display":"201.50","price_state":"stated","total_value":409851.0,"total_display":"409,851.00","total_whole":"409,851","shares_owned_after":33793.0,"shares_owned_after_display":"33,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-03","filed_date":"2026-03-05","scope":"insider"},{"id":2753637,"accession":"0001104659-24-031806","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-031806","line_url":"/filing/0001104659-24-031806#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001442372","owner_name":"Sabba Stephen L","owner_display_name":"Sabba Stephen L","owner_url":"/insider/0001442372","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1893.0,"shares_display":"1,893","price_per_share":74.3,"price_display":"74.30","price_state":"stated","total_value":140649.9,"total_display":"140,649.90","total_whole":"140,650","shares_owned_after":28926.0,"shares_owned_after_display":"28,926","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-07","scope":"insider"},{"id":8622843,"accession":"0001104659-23-059680","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-059680","line_url":"/filing/0001104659-23-059680#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001442372","owner_name":"Sabba Stephen L","owner_display_name":"Sabba Stephen L","owner_url":"/insider/0001442372","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6408.0,"shares_display":"6,408","price_per_share":77.1262,"price_display":"77.13","price_state":"stated","total_value":494224.6896,"total_display":"494,224.69","total_whole":"494,225","shares_owned_after":25784.0,"shares_owned_after_display":"25,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-10","filed_date":"2023-05-12","scope":"insider"},{"id":5501765,"accession":"0001104659-21-020672","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-21-020672","line_url":"/filing/0001104659-21-020672","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001442372","owner_name":"Sabba Stephen L","owner_display_name":"Sabba Stephen L","owner_url":"/insider/0001442372","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14670.0,"shares_display":"14,670","price_per_share":208.52915473755965,"price_display":"208.53","price_state":"stated","total_value":3059122.7,"total_display":"3,059,122.70","total_whole":"3,059,123","shares_owned_after":24431.0,"shares_owned_after_display":"24,431","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-11","scope":"insider","n_lines":2},{"id":8379923,"accession":"0001104659-19-043306","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-043306","line_url":"/filing/0001104659-19-043306#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001442372","owner_name":"Sabba Stephen L","owner_display_name":"Sabba Stephen L","owner_url":"/insider/0001442372","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4091.0,"shares_display":"4,091","price_per_share":94.45,"price_display":"94.45","price_state":"stated","total_value":386394.95,"total_display":"386,394.95","total_whole":"386,395","shares_owned_after":23600.0,"shares_owned_after_display":"23,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-31","filed_date":"2019-08-01","scope":"insider"},{"id":6622036,"accession":"0001104659-18-055509","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-18-055509","line_url":"/filing/0001104659-18-055509#line-3","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001442372","owner_name":"Sabba Stephen L","owner_display_name":"Sabba Stephen L","owner_url":"/insider/0001442372","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":255.05,"price_display":"255.05","price_state":"stated","total_value":1275250.0,"total_display":"1,275,250.00","total_whole":"1,275,250","shares_owned_after":26856.0,"shares_owned_after_display":"26,856","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-04","filed_date":"2018-09-06","scope":"insider"},{"id":6384383,"accession":"0001104659-18-017201","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-017201","line_url":"/filing/0001104659-18-017201#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001442372","owner_name":"Sabba Stephen L","owner_display_name":"Sabba Stephen L","owner_url":"/insider/0001442372","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":622.0,"shares_display":"622","price_per_share":180.73,"price_display":"180.73","price_state":"stated","total_value":112414.06,"total_display":"112,414.06","total_whole":"112,414","shares_owned_after":26363.0,"shares_owned_after_display":"26,363","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-12","filed_date":"2018-03-13","scope":"insider"},{"id":4448379,"accession":"0001104659-17-074431","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-074431","line_url":"/filing/0001104659-17-074431#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001442372","owner_name":"Sabba Stephen L","owner_display_name":"Sabba Stephen L","owner_url":"/insider/0001442372","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":925.0,"shares_display":"925","price_per_share":137.25,"price_display":"137.25","price_state":"stated","total_value":126956.25,"total_display":"126,956.25","total_whole":"126,956","shares_owned_after":26985.0,"shares_owned_after_display":"26,985","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-20","filed_date":"2017-12-21","scope":"insider"},{"id":9223274,"accession":"0001104659-14-071521","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-14-071521","line_url":"/filing/0001104659-14-071521#line-1","is_derivative":false,"issuer_cik":"0001442372","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0001442372","owner_cik":"0001442372","owner_name":"Sabba Stephen L","owner_display_name":"Sabba Stephen L","owner_url":"/insider/0001442372","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":43.115,"price_display":"43.12","price_state":"stated","total_value":86230.0,"total_display":"86,230.00","total_whole":"86,230","shares_owned_after":23697.0,"shares_owned_after_display":"23,697","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-09","filed_date":"2014-10-14","scope":"insider"},{"id":6460982,"accession":"0001104659-14-014612","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-14-014612","line_url":"/filing/0001104659-14-014612#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001442372","owner_name":"Sabba Stephen L","owner_display_name":"Sabba Stephen L","owner_url":"/insider/0001442372","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":72.25,"price_display":"72.25","price_state":"stated","total_value":36125.0,"total_display":"36,125.00","total_whole":"36,125","shares_owned_after":20546.0,"shares_owned_after_display":"20,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-27","filed_date":"2014-02-28","scope":"insider"},{"id":8954100,"accession":"0001104659-11-064063","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-11-064063","line_url":"/filing/0001104659-11-064063#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001442372","owner_name":"Sabba Stephen L","owner_display_name":"Sabba Stephen L","owner_url":"/insider/0001442372","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":11.5,"price_display":"11.50","price_state":"stated","total_value":11500.0,"total_display":"11,500.00","total_whole":"11,500","shares_owned_after":12704.0,"shares_owned_after_display":"12,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-14","filed_date":"2011-11-14","scope":"insider"},{"id":8954099,"accession":"0001104659-11-064063","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-11-064063","line_url":"/filing/0001104659-11-064063#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001442372","owner_name":"Sabba Stephen L","owner_display_name":"Sabba Stephen L","owner_url":"/insider/0001442372","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":11.69,"price_display":"11.69","price_state":"stated","total_value":11690.0,"total_display":"11,690.00","total_whole":"11,690","shares_owned_after":11704.0,"shares_owned_after_display":"11,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-10","filed_date":"2011-11-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000886163","name":"LIGAND PHARMACEUTICALS INC","url":"/issuer/0000886163","role":"Director","n_filings":13,"first_seen":"2011-11-14","last_seen":"2026-06-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001442372","retrieved_at":"2026-08-22T18:03:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}